Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Lowering certain hormone levels improves treatment for hair loss in young men.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Finasteride can slow hair loss and promote growth in postmenopausal women.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

STK11 gene polymorphism does not predict metformin response in PCOS.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.